VivoSim Labs, Inc. Share-based Payment Arrangement, Accelerated Cost
VivoSim Labs, Inc. (VIVS) reported Share-based Payment Arrangement, Accelerated Cost of $0 for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost · last filed 2023-08-10
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2023-06-30 was $0.00.
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2023-03-31 was $0.00.
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2022-12-31 was $0.00.
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for the quarter ending 2022-09-30 was $0.00.
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for fiscal 2023 was $0.00.
- VivoSim Labs, Inc. share-based payment arrangement, accelerated cost for fiscal 2022 was $0.00.
| Period end | Share-based Payment Arrangement, Accelerated Cost 3 month | Share-based Payment Arrangement, Accelerated Cost 6 month | Share-based Payment Arrangement, Accelerated Cost 9 month | Share-based Payment Arrangement, Accelerated Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 derived: sum of 2 quarters · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-08-10 | $0.00 derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $0.00 derived: sum of 2 quarters · filed 2023-07-14 | $0.00 derived: sum of 3 quarters · filed 2023-07-14 | $0.00 10-K · filed 2023-07-14 |
| 2022-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | ||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | $0.00 10-K · filed 2022-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |